Quantcast

Latest Boehringer Ingelheim GmbH Stories

2014-07-31 12:29:00

DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Parkinson's Disease Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Parkinson's disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent...

2014-06-27 08:25:26

First biosimilar insulin to receive CHMP positive opinion in the EU INDIANAPOLIS and INGELHEIM, Germany, June 27, 2014 /PRNewswire/ -- The Committee for Medicinal Products for Human Use (CHMP) today issued a positive opinion recommending approval for the investigational compound LY2963016, a new insulin glargine product, for the treatment of type 1 and type 2 diabetes. The new insulin glargine product from Eli Lilly and Company and Boehringer Ingelheim is the first biosimilar insulin...

2014-06-19 23:17:50

Boehringer Ingelheim GmbH, a German pharmaceutical company, recently announced a settlement for approximately 4,000 claims related to injuries and deaths caused by the blood thinner Pradaxa. PHOENIX, AZ (PRWEB) June 19, 2014 The Arizona personal injury firm Phillips Law Group is investigating claims against Boehringer Ingelheim GmbH, the pharmaceutical company who makes the blood thinner Pradaxa. On May 28, a Bloomberg report announced that Boehringer had agreed to settle approximately...

2014-06-19 23:17:43

German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle nearly 4,000 claims against the drug company for injuries and deaths caused by the blood thinner Pradaxa. MCALESTER, OK (PRWEB) June 19, 2014 The Edwards Law Firm, an Oklahoma pharmaceutical litigation firm, continues to investigate and pursue claims regarding Pradaxa, a blood thinner manufactured by Boehringer Ingelheim GmbH. A Bloomberg report on May 28 announced that Boehringer had agreed to pay $650 million...

2014-06-03 23:14:55

German pharmaceutical company Boehringer Ingelheim GmbH has agreed to settle thousands of claims against the drug manufacturer for injuries and deaths caused by the blood thinner Pradaxa. Columbus, Ohio (PRWEB) June 03, 2014 O’Connor, Acciani & Levy, an Ohio pharmaceutical litigation firm, continue to investigate claims regarding Pradaxa, a blood thinner manufactured by German pharmaceutical company Boehringer Ingelheim GmbH. According to a Bloomberg report published on May 28,...

2014-05-31 23:04:13

Greg Coleman Law reviews the impact of Boehringer’s settlement offer and the drugmaker’s motivations in light of the more than 4,000 pending Pradaxa lawsuits in U.S. courts. Knoxville, TN (PRWEB) May 31, 2014 Greg Coleman Law, a Tennessee defective drug litigation law firm, continues to express concerns about the proposed Pradaxa litigation settlement announced by Boehringer Ingelheim GmbH on May 28, 2014. The firm continues to review and investigate claims that the blood thinner...

2014-05-28 23:02:26

The Firm is evaluating Pradaxa bleeding claims on behalf of individuals who allegedly suffered life-threatening episodes of internal hemorrhaging due to their use of Pradaxa. New York, New York (PRWEB) May 28, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to mount in federal court, Bernstein Liebhard LLP notes that the manufacturer of the blood thinner has acknowledged that a number of serious bleeding events were omitted from the original report on a clinical...

2014-05-27 12:31:59

LONDON, May 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Pain Management Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_pain_management_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Pain Management Drugs market will grow at a CAGR of 3.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The...

2014-01-20 12:24:57

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Analyzing the Global Market for Active Pharmaceutical Ingredients The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the...

2013-10-14 23:20:31

Reportbuyer.com just published a new market research report: Global Pulmonary Drug Delivery Systems Market 2012-2016. London (PRWEB) October 14, 2013 TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related